Cite

HARVARD Citation

    Del Mastro, L. et al. (2015). Everolimus-based therapy in patients with hormone receptor-positive, HER2- advanced breast cancer: management considerations. Future oncology. pp. 2251-2254. [Online]. 
  
Back to record